| Literature DB >> 33953670 |
Ting Hun Lee1,2, Waseem A Wani1, Chia Hau Lee1, Kian Kai Cheng2, Sheikh Shreaz3, Syieluing Wong1, Norfadilah Hamdan1, Nurul Alia Azmi1.
Abstract
Edible Bird's Nest (EBN) is the most prized health delicacy among the Chinese population in the world. Although some scientific characterization and its bioactivities have been studied and researched, no lights have been shed on its actual composition or mechanism. The aim of this review paper is to address the advances of EBN as a therapeutic animal bioproduct, challenges and future perspectives of research involving EBN. The methodology of this review primarily involved a thorough search from the literature undertaken on Web of Science (WoS) using the keyword "edible bird nest". Other information were obtained from the field/market in Malaysia, one of the largest EBN-producing countries. This article collects and describes the publications related to EBN and its therapeutic with diverse functional values. EBN extracts display anti-aging effects, inhibition of influenza virus infection, alternative traditional medicine in athletes and cancer patients, corneal wound healing effects, stimulation of proliferation of human adipose-derived stem cells, potentiate of mitogenic response, epidermal growth factor-like activities, enhancement of bone strength and dermal thickness, eye care, neuroprotective and antioxidant effects. In-depth literature study based on scientific findings were carried out on EBN and its properties. More importantly, the future direction of EBN in research and development as health-promoting ingredients in food and the potential treatment of certain diseases have been outlined.Entities:
Keywords: anti-aging; anticancer; antioxidant; bioproduct; edible bird's nest; functional values
Year: 2021 PMID: 33953670 PMCID: PMC8089372 DOI: 10.3389/fphar.2021.626233
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1A pictorial depiction of the steadily growing interest in the research on EBN from 2000 to 2019.
FIGURE 2An overview of white (A), black (B) and red (C) EBNs.
FIGURE 3Total composition (A), amino acid (B), mineral and metal ions (C) in EBN (Marcone, 2005; Ma and Liu, 2012).
FIGURE 4Some of the famous EBN market products based on foods labeled, outlook and, food products. (A) Bird’s nest soup, (B) Bird’s nest instant energy drink, (C) Vietnam bird’s nest powder, (D) Brand new concept EBN powder, (E) Bird’s nest drink, (F) Bird’s nest pudding recipe, (G) Instant Malaysian cubilose nourishing tonic and (H) Bird’s nest granules for supplements. The image is adapted from (Yen, 2015).
Summary of studied effects using EBN extract.
| Pharmacological activities | Sample preparation | Model | Dosage | Control group | Results | Proposed mechanism and suggested acting compound | References |
|---|---|---|---|---|---|---|---|
| Antiviral effects | Water extract (enzyme extraction) | Madin-darby canine kidney cells (MDCK) | 4 mg/ml | Non-hydrolyzed EBN and untreated cells/mice | EBN after being hydrolyzed with pancreatin F, EBN showed potent antiviral properties in MDCK cells and prevented the virus’ hemagglutinin surface protein from binding to erythrocytes | The bioactive compounds (sialic acid or thymol derivatives) in EBN showed the potential effect toward the antiviral properties by inhibiting the viral genes (NA and NS1) |
|
| Suggested acting compound: Sialic acid or thymol derivatives | |||||||
| Anticancer effects | Water extract | Human colonic adenocarcinoma cell (Caco-2) | 5 ppm | Untreated cells | Two commercial EBN samples showed 84 and 115% cell proliferation, respectively. The unprocessed EBN samples collected from 4 zones, east coast (91%), north (35%), and south (47%) also showed the potent in cell proliferation activity | It is suggested that some of the constituents of EBN must be imparting it with potential to kill rapidly dividing cancer cells |
|
| Acid extract | Macrophage cells (RAW) | 5 ppm | Untreated cells | EBN decreases the production of anti-inflammatory TNF-α in RAW cells | The acting compound not suggested nor tested | ||
| Human adipose-derived stem cells proliferation | Enzyme extraction | Human adipose-derived stem cells (hADSCs) | 2000 ppm | Cells were cultures in control medium (DMEM +15% FBS) | EBN extract was strongly found to promote the proliferation of hADSCs mediated by the production of interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) | The production of IL-6 and VEGF was triggered by the activation of activator protein 1 (AP-1) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). The EBN extract induced production of IL-6 and VEGF was inhibited by PD98059 [a p44/42 mitogen-activated protein kinase (MAPK) inhibitor], SB203580 (a p38 MAPK inhibitor) and ammonium pyrrolidinedithiocarbamate (PDTC; an NF-κB inhibitor). Thus, EBN extract-induced proliferation of hADSCs occurred primarily through amplified expression of IL-6 and VEGF genes, which was mediated by the activation of NF-κB and AP-1 through p44/42 MAPK and p38 MAPK. |
|
| Epidermal growth factor-like activity | Water extract | Primary mouse embryonic fibroblast cell (3T3 fibroblasts) | 0.016–2 ng/ml | Glucosamine | EBN stimulated thymidine incorporation in 3T3 fibroblasts cell culture, and this study proved the presence of EGF in EBN. | EGF are known to stimulate DNA synthesis. This study proved DNA synthesis occurred by detecting the present of thymidine |
|
| Enhancement of bone strength | Enzyme extraction | Female sprague-dawley rats | 100 mg/kg | Fed an AIN93G-based normal diet | The femur of ovariectomized rats that treated with EBN extract showed the increment of calcium level and bone strength ability. Dermal thickness also increased and serum estradiol concentration was not affected by the administration of EBN extract | Estrogen production causes rapid bone loss during first decade after menopause. It was suggested that EBN extract effectively improve bone strength and at the same time regulates the serum estradiol concentration |
|
| Hot-water extraction | Human articular chondroytes cell (HACs) | 0.05–1.00% | Untreated cells | EBN extract increased HACs proliferation, reduced the catabolic genes expression and production of prostaglandin E2 (PGE2). In anabolic activity analysis, type II collagen, aggrecan and SOX-9 gene expression and total sulfated glycosaminoglycan production were increased | EBN extract able to down-regulate matrix metalloproteinases (MMP), cytokines and other catabolic mediator expression that can reduce destruction of cartilage and the degenerative progression of osteoarthritic cartilage | ||
| Eye care effects | Water extract | Rabbit corneal keratocytes cell | 0.05 and 1% | Untreated cells | Low concentration of EBN synergistically induced cell proliferation, especially in serum-containing medium. The corneal keratocytes reserved their phenotypes with the addition of EBN, which was confirmed by both phase contrast micrographs and gene expression analysis | EBN induce corneal cell proliferation and also capable to maintain their phenotypes and functionality by synthesizing stromal constituents in maintaining corneal cells |
|
| This confirmed by increased functional gene expression of collagen type 1, ALDH and lumican which are important corneal keratocytes cell proliferation | |||||||
| The acting compound not suggested nor tested | |||||||
| Neuroprotective effects | Water extraction | Human neuroblastoma cell SH-SY5Y | 100 μg/ml for crude extract and 200 μg/ml for water extract | Untreated cells | EBN treatment reduces the level of 6-hydroxydopamine-induced apoptotic changes in SH-SY5Y cells that was revealed by morphological and nuclear staining observations | EBN extract more potent in improving reactive oxygen species (ROS) build up, early apoptotic membrane phosphatidylserine externalization and the inhibition of caspase-3 cleavage. This report clearly indicated that EBN extracts might induce neuroprotective effects against 6-hydroxydopamine-induced degeneration of dopaminergic neurons via inhibition of apoptosis |
|
| Water extract | Human neuroblastoma cell (SH-SY5Y) | 1,000 μg/ml | Untreated cells | EBN and its content (lactoferrin and ovotransferrin) attenuated H2O2- induced cytotoxicity and decreased radical oxygen species through increased scavenging activity | This report indicated that EBN acts as a neuroprotective (SH-SY5Y human neuroblastoma cell) agent against H2O2- induced cytotoxicity and cell oxidative stress | ||
| Suggested acting compound: Lactoferrin and ovotransferrin | |||||||
| Antioxidant effects | Water extract | Human neuroblastoma cell (SH-SY5Y) | 1,000 μg/ml | Untreated cells | EBN demonstrated protective effects against hydrogen peroxide-induced toxicity and cell oxidative stress on SH-SY5Y cells. Lactoferrin and ovotransferrin also possess antioxidant capacities on SH-SY5Y cells | EBN and its ingredients diminished hydrogen peroxide-induced cytotoxicity, and decreased ROS through increased scavenging activity. Lactoferrin and ovotransferrin in EBN could be contributing toward overall functional properties of EBN |
|
| Suggested acting compound: Lactoferrin and ovotransferrin | |||||||
| Erectile dysfunction | Water extract (enzyme extraction) | Castrated male wistar rats | 1 mg/kg/day | Un-castrated rats | Castrated rat treated with 9 mg/kg/day of EBN extract exhibited significant higher testosterone and luteinizing hormone level. The penis index was observed to be significantly higher | Authors speculated with the increased dosage of EBN extract (9 mg/kg/day) that contributed to the sexual functions |
|
| 3 and 9 mg/kg/day | Suggested acting compound: Testoterone but no evidence of EBN extract it contains |